November 13, 2019
MGC Pharma announced it's received government funding for its clinical trial with the University of Notre Dame Western Australia.
November 5, 2019
MGC Pharmaceuticals shared with investors its financial report for its most recent quarter.
October 31, 2019
MGC Pharmaceuticals announced an increase in patient numbers and reported progress on its LSE listing in its September quarterly report.
October 30, 2019
MGC Pharmaceuticals issued a notice for its annual general meeting set to take place on November 29, 2019.
October 29, 2019
MGC Pharmaceuticals, a cannabinoid medicines maker, has passed 800 patients with prescriptions of its products in Australia and the UK.